These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36046692)

  • 41. Isoproterenol-induced hypertrophy of neonatal cardiac myocytes and H9c2 cell is dependent on TRPC3-regulated Ca
    Han JW; Kang C; Kim Y; Lee MG; Kim JY
    Cell Calcium; 2020 Dec; 92():102305. PubMed ID: 33069962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models.
    Cheng KC; Li Y; Chang WT; Chen ZC; Cheng JT; Tsai CC
    J Food Drug Anal; 2019 Jan; 27(1):355-364. PubMed ID: 30648591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
    Dai H; Jia G; Liu X; Liu Z; Wang H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperhomocysteinemia-induced Nrf2/HO-1 pathway suppression aggravates cardiac remodeling of hypertensive rats.
    Cao P; Zhang W; Kong X; Gao N; Zhao X; Xu R
    Biochem Biophys Res Commun; 2021 Apr; 547():125-130. PubMed ID: 33610040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Folic acid enhances the cardiovascular protective effect of amlodipine in renal hypertensive rats with elevated homocysteine.
    Li L; Tong X; Ma Z; Lv L; Liu H; Chen GL
    Clin Exp Hypertens; 2023 Dec; 45(1):2205058. PubMed ID: 37154141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
    Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC
    J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
    Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
    J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation.
    Chen C; Shen L; Cao S; Li X; Xuan W; Zhang J; Huang X; Bin J; Xu D; Li G; Kitakaze M; Liao Y
    PLoS One; 2014; 9(8):e104040. PubMed ID: 25089522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells.
    Asadi F; Razmi A; Dehpour AR; Shafiei M
    J Pharm Pharmacol; 2016 Apr; 68(4):485-93. PubMed ID: 26945895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of Homocysteine on the Differentiation of CD4
    Gao X; Li J; Chen M
    Dig Dis Sci; 2018 Dec; 63(12):3339-3347. PubMed ID: 29974377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dexamethasone promotes hypertrophy of H9C2 cardiomyocytes through calcineurin B pathway, independent of NFAT activation.
    Sangeetha KN; Lakshmi BS; Niranjali Devaraj S
    Mol Cell Biochem; 2016 Jan; 411(1-2):241-52. PubMed ID: 26511233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
    Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E
    Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiomyocyte calcineurin is required for the onset and progression of cardiac hypertrophy and fibrosis in adult mice.
    Martínez-Martínez S; Lozano-Vidal N; López-Maderuelo MD; Jiménez-Borreguero LJ; Armesilla ÁL; Redondo JM
    FEBS J; 2019 Jan; 286(1):46-65. PubMed ID: 30548183
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.
    Markandeya YS; Phelan LJ; Woon MT; Keefe AM; Reynolds CR; August BK; Hacker TA; Roth DM; Patel HH; Balijepalli RC
    J Biol Chem; 2015 Sep; 290(36):22085-100. PubMed ID: 26170457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy.
    Facundo HT; Brainard RE; Watson LJ; Ngoh GA; Hamid T; Prabhu SD; Jones SP
    Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2122-30. PubMed ID: 22408028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Folic acid and vitamin B(12) supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats.
    Hagar HH
    Pharmacol Res; 2002 Sep; 46(3):213-19. PubMed ID: 12220963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcineurin-NFATc regulates type 2 inositol 1,4,5-trisphosphate receptor (InsP3R2) expression during cardiac remodeling.
    Sankar N; deTombe PP; Mignery GA
    J Biol Chem; 2014 Feb; 289(9):6188-98. PubMed ID: 24415751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
    Chen Y; Yuan J; Jiang G; Zhu J; Zou Y; Lv Q
    Mol Med Rep; 2017 Oct; 16(4):4545-4552. PubMed ID: 28849081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NRP1 regulates HMGB1 in vascular endothelial cells under high homocysteine condition.
    Ma Y; Zhang Z; Chen R; Shi R; Zeng P; Chen R; Leng Y; Chen AF
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1039-H1046. PubMed ID: 30767669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.